These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17672493)

  • 1. Binding of antitumor ruthenium complexes to DNA and proteins: a theoretical approach.
    Besker N; Coletti C; Marrone A; Re N
    J Phys Chem B; 2007 Aug; 111(33):9955-64. PubMed ID: 17672493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to DNA purine base and structure-activity relationship of a series of structurally related Ru(II) antitumor complexes: a theoretical study.
    Chen JC; Chen LM; Xu LC; Zheng KC; Ji LN
    J Phys Chem B; 2008 Aug; 112(32):9966-74. PubMed ID: 18630950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
    Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of organometallic ruthenium(II) anticancer compounds to nucleobases: a computational study.
    Gossens C; Tavernelli I; Rothlisberger U
    J Phys Chem A; 2009 Oct; 113(43):11888-97. PubMed ID: 19791792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on DNA-binding and in vitro antitumor activity of enantiomeric ruthenium(II) complexes.
    Hong WX; Huang F; Huan T; Xu X; Han Q; Wang G; Xu H; Duan S; Duan Y; Long X; Liu Y; Hu Z
    J Inorg Biochem; 2018 Mar; 180():54-60. PubMed ID: 29245062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-binding and photoactivated enantiospecific cleavage of chiral polypyridyl ruthenium(II) complexes.
    Zhang QL; Liu JH; Liu JZ; Zhang PX; Ren XZ; Liu Y; Huang Y; Ji LN
    J Inorg Biochem; 2004 Aug; 98(8):1405-12. PubMed ID: 15271518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium(II) complexes.
    Chen X; Gao F; Zhou ZX; Yang WY; Guo LT; Ji LN
    J Inorg Biochem; 2010 May; 104(5):576-82. PubMed ID: 20167375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium(II) complexes of bipyridine-glycoluril and their interactions with DNA.
    Deshpande MS; Kumbhar AA; Kumbhar AS; Kumbhakar M; Pal H; Sonawane UB; Joshi RR
    Bioconjug Chem; 2009 Mar; 20(3):447-59. PubMed ID: 19236020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and DNA-binding studies of two ruthenium(II) complexes containing one ancillary ligand of bpy or phen: [Ru(bpy)(pp[2,3]p)2](ClO4)2 and [Ru(phen)(pp[2,3]p)2](ClO4)2.
    Wu BY; Gao LH; Duan ZM; Wang KZ
    J Inorg Biochem; 2005 Aug; 99(8):1685-91. PubMed ID: 16005071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium(II) polypyridyl complexes.
    Liu YJ; Zeng CH; Yao JH; Wu FH; He LX; Huang HL
    Chem Biodivers; 2010 Jul; 7(7):1770-83. PubMed ID: 20658665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis, characterization and DNA binding properties of the first chloro(polypyridyl)ruthenium conjugated peptide complex.
    Karidi K; Garoufis A; Hadjiliadis N; Reedijk J
    Dalton Trans; 2005 Feb; (4):728-34. PubMed ID: 15702184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA.
    Caruso F; Monti E; Matthews J; Rossi M; Gariboldi MB; Pettinari C; Pettinari R; Marchetti F
    Inorg Chem; 2014 Apr; 53(7):3668-77. PubMed ID: 24611608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the "piano-stool" [ruthenium(II) (eta6-arene)(en)CL]+ complexes with water and nucleobases; ab initio and DFT study.
    Futera Z; Klenko J; Sponer JE; Sponer J; Burda JV
    J Comput Chem; 2009 Sep; 30(12):1758-70. PubMed ID: 19090568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
    Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
    J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical insights into the interaction of Ru(II) polypyridyl complexes with the RNA triplex poly(U)•poly(A)*poly(U). Intercalative ligand shape effect on third-strand stabilization.
    Tan L; Xie L; Sun X; Zeng L; Yang G
    J Inorg Biochem; 2013 Mar; 120():32-8. PubMed ID: 23268790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.